Stock Quotes in this Article: ACAD, CYCC, NYMX, GALE

WINDERMERE, Fla. (Stockpickr) -- At Stockpickr, we track daily portfolios of stocks that are the biggest percentage gainers and the biggest percentage losers.

Stocks that are making large moves like these are favorites among short-term traders because they can jump into these names and try to capture some of that massive volatility. Stocks that are making big-percentage moves either up or down are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.

>>5 Big Stocks to Trade for Big Gains

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining technical indicators with fundamental trends, discipline and sound money management, you will be well on your way to investment success.

With that in mind, let's take a closer look at a several stocks under $10 that are making large moves to the upside today.

Galena Biopharma

Galena Biopharma (GALE) is a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using targeted biotherapeutics. This stock is trading up 6.8% to $2.01 in recent trading.

Today’s Range: $1.95-$2.07

52-Week Range: $0.36-$3.54

Volume: 1.7 million

Three-Month Average Volume: 1.3 million

>>3 Hot Stocks to Trade (or Not)

From a technical perspective, GALE is trending higher here with above-average volume. This move is quickly pushing GALE within range of triggering a major breakout trade. That trade will hit once GALE manages to clear some near-term overhead resistance levels at $2.19 to $2.30 with high volume.

Traders should now look for long-biased trades in GALE as long as it’s trending above its 50-day at $1.83, and then once it sustains a move or close above those breakout levels with volume that hits near or above 1.3 million shares. If that breakout triggers soon, then look for GALE to re-test or possibly take out its next major overhead resistance levels at $2.50 to $2.75. Any high-volume move above $2.75 will put $3.54 into focus for GALE.

Acadia Pharmaceuticals

Acadia Pharmaceuticals (ACAD) is focused on the development and commercialization of small molecule drugs for the treatment of central nervous system disorders. This stock is trading up 9.4% to $2.38 in recent trading.

Today’s Range: $2.19-$2.40

52-Week Range: $0.93-$3.06

Volume: 1 million

Three-Month Average Volume: 1.2 million

>>5 Stocks Under $10 Set to Soar

From a technical perspective, ACAD is bouncing strongly here right off its 50-day moving average of $2.21 with decent volume. This move is quickly pushing ACAD within range of triggering a near-term breakout trade. That trade will hit once ACAD manages to take out some near-term overhead resistance at $2.64 with high volume.

Traders should now look for long-biased trades in ACAD as long as its trending above its 50-day, and then once it sustains a move or close above $2.64 with volume that hits near or above 1,180,710 shares. If that breakout triggers soon, then look for ACAD to setup to re-test or take out its next major overhead resistance levels at $3.06 to $3.30. Any high-volume move above $3.30 could setup ACAD to trend north of $4.

Nymox Pharmaceutical

Nymox Pharmaceutical (NYMX) is a biopharmaceutical company engaged in the research and development of diagnostics and drugs for brain disorders and diseases of the aged with an emphasis on Alzheimer's disease. This stock is trading up 15.8% to $7.25 in recent trading.

Today’s Range: $6.45-$7.42

52-Week Range: $5.69-$9.50

Volume: 115,000

Three-Month Average Volume: 31,755

>>5 Stocks With Big Insider Buying

From a technical perspective, NYMX is exploding higher here right off its 50-day at $6.33 with above-average volume. This move has also started to push NYMX back above its 200-day at $7.22.

Traders should now look for long-biased trades in NYMX as long as it’s trending above its 200-day at $7.22 with strong upside volume flows. I would consider any upside volume day that registers near or above its three-month average action of 31,755 shares as bullish. If NYMX can sustain that trend, then this stock has a great chance of re-testing or possibly taking out its next major overhead resistance levels at $8.28 to $8.42. Any high-volume move above $8.40 will put $8.98 to $9.50 into focus for NYMX.

Cyclacel Pharmaceuticals

Cyclacel Pharmaceuticals (CYCC) is a development-stage biopharmaceutical company dedicated to the development and commercialization of novel, mechanism-targeted drugs to treat human cancers and other serious diseases. This stock is trading up 7.8% to $7 in recent trading.

Today’s Range: $6.41-$7.40

52-Week Range: $2.73-$7.93

Volume: 369,000

Three-Month Average Volume: 128,783

>>4 Stocks Showing Strength in a Weak Market

From a technical perspective, CYCC is ripping higher here with above-average volume. This move is quickly pushing CYCC within range of triggering a major breakout trade. That trade will hit once CYCC manages to take out some near-term overhead resistance at $7.93 with high volume.

Traders should now look for long-biased trades in CYCC as long as it’s trending above today’s low of $6.41, and then once it sustains a move or close above $7.93 with volume that hits near or above 128,783 shares. If that breakout triggers soon, then CYCC will set up to re-test or possibly take out its next major overhead resistance levels at $9 to $10.

To see more stocks under-$10 that are making notable moves higher today, check out the Stocks Under $10 Moving Higher portfolio on Stockpickr.

-- Written by Roberto Pedone in Winderemere, Fla.


RELATED LINKS:







Follow Stockpickr on Twitter and become a fan on Facebook.

At the time of publication, author had no positions in stocks mentioned.

Roberto Pedone, based out of Windermere, Fla., is an independent trader who focuses on stocks, options, futures, commodities and currencies. He is also an outside contributor to Beconequity.com and maintains the website Maddmoney.net, which he sold to Blue Wave Advisors in 2008. Roberto studied International Business at The Milwaukee School of Engineering, and he spent a year overseas studying business in Lubeck, Germany.